Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 9/20 | 0.42 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.40 |
| ▸ | ST14 | Q9Y5Y6 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.37 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.37 |
| ▸ | CFD | P00746 | 1/20 | 0.37 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.37 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.37 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.37 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | PLAU | P00749 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18800882 | 0.93 | BTK (0.42) | BTKTNK2MAPTNPSR1NR1H2 | |
| SCHEMBL18800574 | 0.92 | BTK (0.42) | BTKTNK2MAPTNPSR1NR1H2 | |
| SCHEMBL18800748 | 0.89 | BTK (0.42) | BTKTNK2MAPTNPSR1NR1H2 | |
| SCHEMBL18800866 | 0.88 | FFAR1 (0.44) | — | |
| SCHEMBL18800492 | 0.87 | BTK (0.48) | BTKTNK2 | |
| SCHEMBL18800775 | 0.86 | TNK2 (0.48) | BTKTNK2MAPTNPSR1 | |
| SCHEMBL18800616 | 0.86 | BTK (0.47) | BTKTNK2 | |
| SCHEMBL18800753 | 0.86 | BTK (0.49) | BTKTNK2 | |
| SCHEMBL18800769 | 0.85 | ADORA2A (0.48) | BTKTNK2MAPT | |
| SCHEMBL16168189 | 0.85 | AURKA (0.40) | BTKTNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2789615-B1 | Azaindazoles as Btk kinase modulators and use thereof | BRISTOL MYERS SQUIBB CO (US) | 2017-05-03 | — | — | EP | disclosed |